Synthetic Peptide YY Analog Binds to a Cell Membrane Receptor and Delivers Fluorescent Dye to Pancreatic Cancer Cells

Journal of Gastrointestinal Surgery

Volumn 5, Issue 2, 2001, Pages 147-152

  Liu, Carson D ^a   Kwan, David ^a   Simon, Natalie ^a   McFadden, David W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biotin; Pancreatic cancer; Peptide YY

Indexed keywords

CELL SURFACE RECEPTOR; DIAGNOSTIC AGENT; FLUORESCENT DYE; PEPTIDE FRAGMENT; PEPTIDE YY; PEPTIDE YY (22 36); PEPTIDE YY (22-36);

ARTICLE; BIOTINYLATION; CELL CULTURE; FLOW CYTOMETRY; HUMAN; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR;

BIOTINYLATION; CARCINOMA, PANCREATIC DUCTAL; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PEPTIDE YY; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 0035294402     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)80026-3     Document Type: Article

References (11)

1. Cancer Facts and Figures-1994. Atlanta, Ga: American Cancer Society, 1994.
2. Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK, eds. Cancer Statistics Review: 1973-1989. National Cancer Institute. NIH Publication 1992;92:2789.
3. Kaiser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120;899-903.
4. Steele GD, Osteen RT, Winchester DP, Menck HR, Murphy GP. National Cancer Data Base Annual Review of Patient Care. American Cancer Society Publication 54, 1994.
5. Hoyt DW, Harkins RN, Debanne MT, O'Connor-McCourt M, Sykes BD. Interaction of transforming growth factor alpha with the epidermal growth factor receptor: Binding kinetics and differential mobility within the bound TGF alpha. Biochemistry 1994;33:15283-15292.
6. Liu CD, Balasubramaniam A, Saxton RE, Paiva M, McFadden DW. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. J Surg Res 1995;58:707-712.
7. Liu CD, Slice L, Balasubramaniam A, Walsh JH, Newton TR, Saxton RE, McFadden DW. Y2 receptors decrease human pancreatic cancer growth and intracellular cAMP levels. Surgery 1995;118:229-236.
8. Liu CD, Rongione AJ, Garvey L, Balasubramaniam A, McFadden DW. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth and EGF receptor expression. AmJ Surg 1996;171:192-196.
9. Reymound MT, Delmas L, Koerher SC, Brown MR, Rivier JR. Truncated, branched, and/or cyclic analogues of neuropeptide Y: Importance of the pancreatic peptide fold in the design of specific Y2 receptor ligands. J Med Chem 1992; 35:3653-3659.
10. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semi-automated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 1987;47:936.
11. Blomqvist AG, Herzog H. Y receptor subtypes - how many more! Trends Neurosci 1997;20:294-298.